Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

TLSI

TriSalus Life Sciences (TLSI)

TriSalus Life Sciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TLSI
DateTimeSourceHeadlineSymbolCompany
05/24/20245:05AMBusiness WireTriSalus Life Sciences Announces Commencement of Exchange Offer and Consent Solicitation Relating to WarrantsNASDAQ:TLSITriSalus Life Sciences Inc
05/15/20247:00AMBusiness WireTriSalus Reports Q1 2024 Financial Results and Business UpdateNASDAQ:TLSITriSalus Life Sciences Inc
05/07/20246:00AMBusiness WireTriSalus Life Sciences Appoints Liselotte Hyveled to its Board of DirectorsNASDAQ:TLSITriSalus Life Sciences Inc
05/06/20243:58PMBusiness WireTriSalus Life Sciences to Host First Quarter 2024 Financial Results Conference CallNASDAQ:TLSITriSalus Life Sciences Inc
04/30/20243:35PMBusiness WireTriSalus Life Sciences Secures up to $50 million of Debt Financing with OrbiMed to Support TriNav® Infusion System Growth InitiativesNASDAQ:TLSITriSalus Life Sciences Inc
04/01/20247:00AMBusiness WireTriSalus Reports Q4 and Full Year 2023 Financial Results and Business UpdateNASDAQ:TLSITriSalus Life Sciences Inc
03/26/20247:00AMBusiness WireTriSalus Life Sciences Technology Featured in Two Presentations at the Society of Interventional Radiology Annual Scientific MeetingNASDAQ:TLSITriSalus Life Sciences Inc
03/21/20247:00AMBusiness WireTriSalus Life Sciences Announces Oral Presentations at the Upcoming 2024 Society of Interventional Radiology (SIR) Annual Scientific MeetingNASDAQ:TLSITriSalus Life Sciences Inc
03/11/20244:15PMBusiness WireTriSalus Life Sciences Announces Q4 Conference Call and Preliminary and Unaudited Q4 and Full Year 2023 Financial ResultsNASDAQ:TLSITriSalus Life Sciences Inc
03/07/20246:00AMBusiness WireTriSalus Life Sciences Receives Approval from the World Health Organization and the American Medical Association’s Adopted Name Council for “Nelitolimod” as the Nonproprietary Drug Name for SD-101NASDAQ:TLSITriSalus Life Sciences Inc
02/29/20246:00AMBusiness WireTriSalus Life Sciences Announces Real-World Data Demonstrating the Ability of TriNav® to Successfully Treat Patients with Higher Disease Burden and to Improve Delivery of Therapeutics to Liver TumorsNASDAQ:TLSITriSalus Life Sciences Inc
02/14/20245:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TLSITriSalus Life Sciences Inc
02/14/20245:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TLSITriSalus Life Sciences Inc
02/14/20245:36PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TLSITriSalus Life Sciences Inc
02/14/20245:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TLSITriSalus Life Sciences Inc
02/14/20245:13PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TLSITriSalus Life Sciences Inc
01/25/20244:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TLSITriSalus Life Sciences Inc
01/25/20244:23PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:TLSITriSalus Life Sciences Inc
01/25/20244:21PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:TLSITriSalus Life Sciences Inc
01/25/20244:19PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLSITriSalus Life Sciences Inc
01/05/20243:28PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLSITriSalus Life Sciences Inc
12/26/202311:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TLSITriSalus Life Sciences Inc
12/26/202311:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TLSITriSalus Life Sciences Inc
12/26/20234:28PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:TLSITriSalus Life Sciences Inc
12/26/20234:27PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:TLSITriSalus Life Sciences Inc
11/14/20237:00AMBusiness WireTriSalus Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:TLSITriSalus Life Sciences Inc
11/07/20233:05PMBusiness WireTriSalus Life Sciences to Host Third Quarter 2023 Financial Results Conference CallNASDAQ:TLSITriSalus Life Sciences Inc
11/04/20231:25PMBusiness WireLate-Breaking Phase 1 Liver Metastasis Data from TriSalus Presented at SITC 2023 Supports Development of Innovative Immuno-oncology Approach for Liver and Pancreas IndicationsNASDAQ:TLSITriSalus Life Sciences Inc
11/03/202311:00AMBusiness WireTriSalus Life Sciences Presents Data for SD-101 Delivered by TriSalus Infusion System for Pancreatic Adenocarcinoma at the Society for Immunotherapy of Cancer (SITC) Annual MeetingNASDAQ:TLSITriSalus Life Sciences Inc
10/25/20238:05AMBusiness WireTriSalus Life Sciences Announces Late Breaker and Additional Data Presentations on Liver Metastases and Pancreatic Cancer at the Society for Immunotherapy of Cancer (SITC) 2023 Annual MeetingNASDAQ:TLSITriSalus Life Sciences Inc
 Showing the most relevant articles for your search:NASDAQ:TLSI